Hayna Malta-Santos Selected Research

Tamoxifen

1/2018

Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hayna Malta-Santos Research Topics

Disease

5	Cutaneous Leishmaniasis 12/2020 - 02/2015
3	Diffuse Cutaneous Leishmaniasis 01/2020 - 02/2015
1	Necrosis 01/2022
1	Inflammation (Inflammations) 01/2022
1	Overweight 06/2020
1	Leishmaniasis 10/2017
1	Infections 10/2017
1	Mucocutaneous Leishmaniasis 04/2016

Drug/Important Bio-Agent (IBA)

2	PolyaminesIBA 01/2020 - 02/2015
2	EicosanoidsIBA 10/2017 - 04/2016
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Propolis (Bee Bread)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	InterleukinsIBA 01/2022
1	CytokinesIBA 12/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2020
1	Amino Acids FDA Link 01/2020
1	Tamoxifen FDA LinkGeneric 01/2018
1	Meglumine AntimoniateIBA 01/2018
1	resolvin D1IBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	ArginaseIBA 02/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2015
1	Dinoprostone (PGE2)FDA Link 02/2015
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 02/2015

Therapy/Procedure

2	Therapeutics 01/2018 - 10/2017